iSpecimen and myOnsite Deploy Mobile Phlebotomy During Coronavirus Pandemic
iSpecimen has announced a new initiative in the battle against COVID-19 and other diseases, mobile phlebotomy support that will bring at-home sample collection to patients and donors interested in advancing research. The mobile service extends iSpecimen’s ongoing mission to advance medical research by connecting researchers with patients, biospecimens, and the data they need to perform their work.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
